TrialThe American journal of tropical medicine and hygiene2018

Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.

Edford Sinkala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.